Desk› Healthcare› Vivanza Biosciences Ltd

Vivanza Biosciences Ltd

BSE 530057 VIVANZA INE984E01035

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

19 filings · 8 material · busiest 2026-08-07

What it files

Board Meeting4 Board Outcome3 General2 Results2 AGM / EGM1 Annual Report1 Outcome1 KMP1

Filings

19 in the window

20 August 2026

General

Newspaper Publication

Please find enclosed newspaper advertisement w.r.t Notice of 44th AGM of the Company and e-voting information.

Company Update / General View filing →
19 August 2026

AGM / EGM

Notice Of The 44Th Annual General Meeting ('AGM') And Annual Report Of The Company For The Financial Year 2025-26

Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

AGM/EGM / AGM View filing →
19 August 2026

Annual Report

Reg. 34 (1) Annual Report.

Annual Report for the Financial Year 2025-2026 of the Company.

Others / Reg. 34 (1) Annual Report View filing →
17 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026

The Board of Directors of the Company at its meeting held on Monday, August 17, 2026, at the Registered Office, inter alia, considered and approved: 1. Director's Report, Secretarial Audit ....

Board Meeting / Outcome of Board Meeting View filing →
12 August 2026

Board Meeting

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Vivanza Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve 1) To consider and approve ....

Board Meeting / Board Meeting View filing →
7 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026

Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2026, along with year-to-date figures for the period from 1st April, 2026, to 30th ....

Board Meeting / Outcome of Board Meeting View filing →
7 August 2026

Results

Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')

Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 and other items .

Result / Financial Results View filing →
7 August 2026

Results

Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')

Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 and other items .

Result / Financial Results View filing →
31 July 2026

Board Meeting

Update on board meeting

The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026 The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026

Company Update / Board Meeting Rescheduled View filing →
28 July 2026

Board Meeting

Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June, 2026.

Vivanza Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve 1. Unaudited Standalone ....

Board Meeting / Board Meeting View filing →
14 July 2026

General

Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

we hereby declared that statutory auditor of the company M/s Shivam Soni & co, Chartered Accountant (FRN: 152477W) have issued an Audit Report with unmodified opinion on the Audited Financial ....

Company Update / General View filing →
9 July 2026

Outcome

Board Meeting Outcome for Outcome Of The Board Meeting Held On 09Th July, 2026.

Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company was held on ....

Others / Outcome without intimation View filing →
9 July 2026

KMP

Appointment of Company Secretary and Compliance Officer

pursuant to regulation 30 of the SEBI(LODR) Regulations, 2015 appointmnet of Mr. Vishal Sureshbhai Katarmal as a Company Secretary and Compliance Officer has been approved with effect from ....

Company Update / Appointment of Company Secretary / Compliance Officer View filing →
7 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 47(5) of the SEBI ( Depository and Participant) Regulations, 2018, received from Purva Share Registry (I) Pvt Ltd and the share transfer agent (RTA) of the ....

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
29 June 2026

Contract / MoU

Memorandum of Understanding /Agreements

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Strategic Corporation, Investment & Technology Transfer Agreement

Company Update / Memorandum of Understanding /Agreements View filing →
26 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window for the Quarter ended on 30th June 2026

Insider Trading / SAST / Closure of Trading Window View filing →
18 June 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting To Be Held At 18Th June, 2026

1.The Board of Directors of the Company, at its meeting held today, has considered and approved the following transactions. The meeting of the Board of Directors of the Company commenced ....

Board Meeting / Outcome of Board Meeting View filing →
18 June 2026

Change in Management

Change in Management

Pursuant to Reg 29 and other applicable provisions of SEBI LODR Reg, 2015 this is to inform you that a meeting of the Board of Directors of the Company held on 18th June 2026 has considered ....

Company Update / Change in Management View filing →
15 June 2026

Board Meeting

Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Pursuant To Regulations 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Vivanza Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve 1.To authorise Mr. Sarang ....

Board Meeting / Board Meeting View filing →